STOCK TITAN

[Form 4] Sera Prognostics, Inc. Insider Trading Activity

Filing Impact
(Low)
Filing Sentiment
(Negative)
Form Type
4

Sera Prognostics director Sandra AJ Lawrence reported the sale of 3,899 shares of Class A common stock on 09/09/2025 under a Rule 10b5-1 trading plan adopted June 10, 2025. The shares were sold in multiple transactions at prices ranging from $2.99 to $3.12, with a reported weighted-average price of $3.05. After the reported dispositions, the reporting person beneficially owns 18,814 shares. The Form 4 was signed by an attorney-in-fact, Benjamin G. Jackson.

Sandra AJ Lawrence, direttrice di Sera Prognostics, ha dichiarato la vendita di 3.899 azioni di azioni ordinarie di Classe A il 09/09/2025 nell'ambito di un piano di negoziazione ai sensi della Rule 10b5-1 adottato il 10 giugno 2025. Le azioni sono state vendute in più operazioni a prezzi compresi tra $2.99 e $3.12, con un prezzo medio ponderato riportato di $3.05. Dopo tali cessioni la persona segnalante possiede beneficiariamente 18.814 azioni. Il Modulo 4 è stato firmato da un procuratore, Benjamin G. Jackson.

Sandra AJ Lawrence, directora de Sera Prognostics, informó la venta de 3.899 acciones ordinarias Clase A el 09/09/2025 bajo un plan de trading conforme a la Regla 10b5-1 adoptado el 10 de junio de 2025. Las acciones se vendieron en varias transacciones a precios entre $2.99 y $3.12, con un precio promedio ponderado informado de $3.05. Tras dichas disposiciones, la persona informante posee beneficiariamente 18.814 acciones. El Formulario 4 fue firmado por un apoderado, Benjamin G. Jackson.

Sera Prognostics 이사 Sandra AJ Lawrence는 2025년 9월 9일에 10b5-1 규정에 따른 거래 계획(채택일: 2025년 6월 10일)에 따라 클래스 A 보통주 3,899주를 매도했다고 보고했습니다. 해당 주식은 여러 차례 거래로 주당 $2.99~$3.12 범위에서 매각되었고, 보고된 가중평균 가격은 $3.05였습니다. 보고된 처분 후 보고인은 총 18,814주를 실질적으로 보유하고 있습니다. Form 4는 권한 대리인 Benjamin G. Jackson가 서명했습니다.

Sandra AJ Lawrence, administratrice de Sera Prognostics, a déclaré la vente de 3 899 actions ordinaires de Classe A le 09/09/2025 dans le cadre d’un plan de négociation conforme à la Rule 10b5-1 adopté le 10 juin 2025. Les actions ont été vendues en plusieurs transactions à des prix allant de $2.99 à $3.12, avec un prix moyen pondéré déclaré de $3.05. Après ces cessions, la personne déclarante détient bénéficiairement 18 814 actions. Le formulaire 4 a été signé par un mandataire, Benjamin G. Jackson.

Sandra AJ Lawrence, Direktorin von Sera Prognostics, meldete am 09.09.2025 den Verkauf von 3.899 Stammaktien Klasse A im Rahmen eines nach Rule 10b5-1 eingerichteten Handelsplans, der am 10. Juni 2025 angenommen wurde. Die Aktien wurden in mehreren Transaktionen zu Preisen zwischen $2.99 und $3.12 verkauft; der gemeldete gewichtete Durchschnittspreis lag bei $3.05. Nach den gemeldeten Veräußerungen besitzt die meldepflichtige Person wirtschaftlich 18.814 Aktien. Das Formular 4 wurde von einem Bevollmächtigten, Benjamin G. Jackson, unterschrieben.

Positive
  • None.
Negative
  • None.

Insights

TL;DR: Director sold a small block under a pre-established 10b5-1 plan; procedural disclosure appears complete and routine.

The sale of 3,899 shares was executed pursuant to a Rule 10b5-1 plan adopted June 10, 2025, which indicates the transactions were pre-authorized. The filer remains a director and retains 18,814 shares after the sale. The Form 4 discloses the weighted-average sale price and the price range for the multiple transactions, and the filing includes an attorney-in-fact signature. There are no indications of undisclosed related-party transactions or departures from standard Section 16 reporting protocols in the document provided.

TL;DR: Transaction is a routine insider sale under a 10b5-1 plan; no new material operational or financial information disclosed.

The reported disposition reduces the reporting person's stake to 18,814 shares; the sale prices ranged from $2.99 to $3.12 with a weighted average of $3.05. The filing does not include any derivative transactions or additional material disclosures about the issuer's performance. From a market-impact perspective, the disclosed sale size and details suggest a routine liquidity event rather than a material corporate development.

Sandra AJ Lawrence, direttrice di Sera Prognostics, ha dichiarato la vendita di 3.899 azioni di azioni ordinarie di Classe A il 09/09/2025 nell'ambito di un piano di negoziazione ai sensi della Rule 10b5-1 adottato il 10 giugno 2025. Le azioni sono state vendute in più operazioni a prezzi compresi tra $2.99 e $3.12, con un prezzo medio ponderato riportato di $3.05. Dopo tali cessioni la persona segnalante possiede beneficiariamente 18.814 azioni. Il Modulo 4 è stato firmato da un procuratore, Benjamin G. Jackson.

Sandra AJ Lawrence, directora de Sera Prognostics, informó la venta de 3.899 acciones ordinarias Clase A el 09/09/2025 bajo un plan de trading conforme a la Regla 10b5-1 adoptado el 10 de junio de 2025. Las acciones se vendieron en varias transacciones a precios entre $2.99 y $3.12, con un precio promedio ponderado informado de $3.05. Tras dichas disposiciones, la persona informante posee beneficiariamente 18.814 acciones. El Formulario 4 fue firmado por un apoderado, Benjamin G. Jackson.

Sera Prognostics 이사 Sandra AJ Lawrence는 2025년 9월 9일에 10b5-1 규정에 따른 거래 계획(채택일: 2025년 6월 10일)에 따라 클래스 A 보통주 3,899주를 매도했다고 보고했습니다. 해당 주식은 여러 차례 거래로 주당 $2.99~$3.12 범위에서 매각되었고, 보고된 가중평균 가격은 $3.05였습니다. 보고된 처분 후 보고인은 총 18,814주를 실질적으로 보유하고 있습니다. Form 4는 권한 대리인 Benjamin G. Jackson가 서명했습니다.

Sandra AJ Lawrence, administratrice de Sera Prognostics, a déclaré la vente de 3 899 actions ordinaires de Classe A le 09/09/2025 dans le cadre d’un plan de négociation conforme à la Rule 10b5-1 adopté le 10 juin 2025. Les actions ont été vendues en plusieurs transactions à des prix allant de $2.99 à $3.12, avec un prix moyen pondéré déclaré de $3.05. Après ces cessions, la personne déclarante détient bénéficiairement 18 814 actions. Le formulaire 4 a été signé par un mandataire, Benjamin G. Jackson.

Sandra AJ Lawrence, Direktorin von Sera Prognostics, meldete am 09.09.2025 den Verkauf von 3.899 Stammaktien Klasse A im Rahmen eines nach Rule 10b5-1 eingerichteten Handelsplans, der am 10. Juni 2025 angenommen wurde. Die Aktien wurden in mehreren Transaktionen zu Preisen zwischen $2.99 und $3.12 verkauft; der gemeldete gewichtete Durchschnittspreis lag bei $3.05. Nach den gemeldeten Veräußerungen besitzt die meldepflichtige Person wirtschaftlich 18.814 Aktien. Das Formular 4 wurde von einem Bevollmächtigten, Benjamin G. Jackson, unterschrieben.

SEC Form 4
FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response: 0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
X
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Lawrence Sandra AJ

(Last) (First) (Middle)
C/O SERA PROGNOSTICS, INC.
2749 EAST PARLEYS WAY, SUITE 200

(Street)
SALT LAKE CITY UT 84109

(City) (State) (Zip)
2. Issuer Name and Ticker or Trading Symbol
SERA PROGNOSTICS, INC. [ SERA ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
X Director 10% Owner
Officer (give title below) Other (specify below)
3. Date of Earliest Transaction (Month/Day/Year)
09/09/2025
4. If Amendment, Date of Original Filed (Month/Day/Year)
6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Class A Common Stock 09/09/2025 S(1) 3,899 D $3.05(2) 18,814 D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Explanation of Responses:
1. The transaction(s) reported on this Form 4 was/were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 10, 2025.
2. The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $2.99 to $3.12, inclusive. The Reporting Person will provide to the staff of the Securities and Exchange Commission, the issuer, or any security holder of the issuer, upon request, full information regarding the number of shares sold at each separate price.
/s/ Benjamin G. Jackson, Attorney-in-fact 09/09/2025
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What insider activity did SERA director Sandra AJ Lawrence report on Form 4?

The director reported the sale of 3,899 shares of Class A common stock on 09/09/2025 under a Rule 10b5-1 trading plan.

What price did Sandra AJ Lawrence receive for the SERA shares sold?

The shares were sold at prices ranging from $2.99 to $3.12, with a reported weighted-average price of $3.05.

How many SERA shares does the reporting person own after the sale?

After the reported transactions the reporting person beneficially owns 18,814 shares.

Was the sale part of a pre-established trading plan?

Yes. The Form 4 states the transactions were effected pursuant to a Rule 10b5-1 trading plan adopted on June 10, 2025.

Who signed the Form 4 for the reporting person?

The Form 4 was signed by Benjamin G. Jackson, attorney-in-fact, on 09/09/2025.
Sera Prognostics, Inc.

NASDAQ:SERA

SERA Rankings

SERA Latest News

SERA Latest SEC Filings

SERA Stock Data

122.18M
32.89M
10.8%
64.96%
1.88%
Medical Devices
Services-medical Laboratories
Link
United States
SALT LAKE CITY